Fertility and Sterility
Volume 78, Issue 1 , Pages 58-62 , July 2002

Hereditary thrombophilias are not associated with a decreased live birth rate in women with recurrent miscarriage

  • Howard Carp, B.S. (M.B., F.R.C.O.G.)

      Affiliations

    • Corresponding Author InformationReprint requests: Howard Carp, M.B., B.S., F.R.C.O.G., Department of Obstetrics and Gynecology, Sheba Medical Center, Tel Hashomer, 52621, Israel (FAX: 972-9-9574779)
    • Department of Obstetrics and Gynecology, Sheba Medical Center, Tel Hashomer, Israel
    • Department of Embryology, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
    • ,
  • Mordechai Dolitzky, M.D.

      Affiliations

    • Department of Obstetrics and Gynecology, Sheba Medical Center, Tel Hashomer, Israel
    • ,
  • Ilan Tur-Kaspa, M.D.

      Affiliations

    • IVF Unit, Barzilai Medical Center, Ashkelon, Israel
    • ,
  • Aida Inbal, M.D.

      Affiliations

    • Institute of Thrombosis and Hemostasis, Sheba Medical Center, Tel Hashomer, Israel

Received 23 October 2001 ,Revised 26 December 2001 ,Accepted 26 December 2001.

References 

  1. Salat-Baroux J. Recurrent spontaneous miscarriages. Reprod Nutr Dev. 1998;28:1555–1568
  2. Crosignani PC, Rubin BL. Recurrent spontaneous miscarriage. The recommendations of the ESHRE workshop on recurrent spontaneous miscarriage held in Anacapri on September 9–11, 1990. Hum Reprod. 1991;6:609–610
  3. Stirling Y, Woolf L, North WR, Seghatchian MJ, Meade TW. Haemostasis in normal pregnancy. Thromb Haemost. 1984;52:176–182
  4. Comp PC, Thurnau GR, Welsh J, Esmon CT. Functional and immunologic protein S levels are decreased during pregnancy. Blood. 1986;68:881–885
  5. Wilson WA, Gharavi AE, Koike T, Lockshin MD, Ware Branch D, Piete JC, et al.  International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome. Arthritis Rheum. 1999;42:1309–1311
  6. De Wolf F, Carreras LO, Moerman P, Vermylen J, Van Assche A, Renaer M. Decidual vasculopathy and extensive placental infarction in a patient with repeated thromboembolic accidents, recurrent fetal loss, and a lupus anticoagulant. Am J Obstet Gynecol. 1982;142:829–834
  7. Seligsohn U, Lubetsky A. Genetic susceptibility to venous thrombosis. N Engl J Med. 2001;344:1222–1231
  8. Preston FE, Rosendaal FR, Walker ID, Briot E, Berntorp E, Conard J, et al.  Increased fetal loss in women with heritable thrombophilia. Lancet. 1996;348:913–916
  9. Grandone E, Margaglione M, Colaizzo D, D’Addedda M, Cappucci G, Vecchione G, et al.  Factor V Leiden is associated with repeated and recurrent unexplained fetal losses. Thromb Haemost. 1997;77:822–824
  10. Rai R, Regan L, Hadley E, Dave M, Cohen H. Second-trimester pregnancy loss is associated with activated C resistance. Br J Haematol. 1996;92:489–490
  11. Martinelli I, Taioli E, Cetin I, Marinoni A, Gerosa S, Villa MV, et al.  Mutations in coagulation factors in women with unexplained late fetal loss. N Engl J Med. 2000;343:1015–1018
  12. Tal J, Schliamser LM, Leibovitz Z, Ohel G, Attias D. A possible role for activated protein C resistance in patients with first and second trimester pregnancy failure. Hum Reprod. 1999;14:1624–1627
  13. Egeberg O. Inherited antithrombin III deficiency causing thrombophilia. Thromb Diath Haemorrh. 1965;13:516–530
  14. Beck EA, Charache P, Jackson DP. A new inherited coagulation disorder caused by an abnormal fibrinogen (‘fibrinogen Baltimore’). Nature. 1965;208:143–145
  15. Griffin JH, Evatt B, Zimmerman TS, Kleiss AJ, Wideman C. Deficiency of protein C in congenital thrombotic disease. J Clin Invest. 1981;68:1370–1373
  16. Comp PC, Esmon CT. Recurrent venous thromboembolism in patients with a partial deficiency of protein S. N Engl J Med. 1984;311:1525–1528
  17. Bertina RM, Koelman BP, Koster T, Rosendaal FR, Dirven RJ, de Ronde HET, et al.  Mutation in the blood coagulation factor V associated with resistance to activated protein C. Nature. 1994;369:64–67
  18. Arruda VR, Von Zuben PM, Chiapurini LC, Annichino-Bizzachi JM, Costa FF. The mutation Ala677-Val in the methylene tetrahydrofolate reductase gene (a risk factor for arterial disease and venous thrombosis). Thromb Haemost. 1997;77:818–821
  19. Poort SR, Rosendahl FR, Reissma PH, Bertina RM. A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels, and an increase in venous thrombosis. Blood. 1996;88:3698–3703
  20. Younis JS, Ohel G, Brenner B, Ben-Ami M. Familial thrombophilia—the scientific rationale for thrombophylaxis in recurrent pregnancy loss. Hum Reprod. 1997;12:1389–1390
  21. Brenner B, Hoffman R, Blumenfeld Z, Weiner Z, Younis JS. Gestational outcome in thrombophilic women with recurrent pregnancy loss treated by enoxaparin. Thromb Hemost. 2000;83:693–697
  22. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure of extracting DNA from human nucleated cells. Nucl Acid Res. 1988;16:1215–1217
  23. Salomon O, Steinberg DM, Zivelin A, Gitel S, Dardik R, Rosenberg N, et al.  Single and combined prothrombotic factors in patients with idiopathic venous thromboembolism. Arterioscler Thromb Vasc Biol. 1999;19:511–518
  24. Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, et al.  A candidate genetic risk factor for vascular disease (a common mutation in methylenetetrahydrofolate reductase). Nat Genet. 1995;10:111–113
  25. Carp HJA. Abstracts of contributors’ individual data submitted to the worldwide prospective observation study on immunotherapy for treatment of recurrent spontaneous abortion. Am J Reprod Immunol. 1994;32:261–274
  26. Brenner B, Mandel H, Lanir N, Younis J, Rothbart H, Ohel G, et al. Activated protein C resistance can be associated with recurrent fetal loss. Br J Haematol. 1997;97:551–554
  27. Ridker PM, Miletich JP, Buring JE, Ariyo AA, Price DT, Manson JE, et al.  Factor V Leiden mutation as a risk factor for recurrent pregnancy loss. Ann Intern Med. 1998;128:100–103
  28. Rai R, Shlebak A, Cohen H, Backos M, Holmes Z, Marriott K, et al.  Factor V Leiden and acquired activated protein C resistance among 1000 women with recurrent miscarriage. Hum Reprod. 2001;16:961–965
  29. Raziel A, Kornberg Y, Friedler S, Schachter M, Sela BA, Ron-El R. Hypercoagulable thrombophilic defects and hyperhomocystinemia in patients with recurrent pregnancy loss. Am J Reprod Immunol. 2001;45:65–71
  30. Dizon-Townson DS, Kinney S, Branch DW, Wand K. The factor V Leiden mutation is not a common cause of recurrent miscarriage. J Reprod Immunol. 1997;34:217–223
  31. Holmes ZR, Regan L, Chilcott I, Cohen H. The C677T MTHFR gene mutation is not predictive of risk for recurrent fetal loss. Br J Haematol. 1999;105:98–101
  32. Kutteh WH, Park VM, Deitcher SR. Hypercoagulable state mutation analysis in white patients with early first-trimester recurrent pregnancy loss. Fertil Steril. 1998;71:1048–1054
  33. Yamada H, Kato EH, Kobashi G, Ebina Y, Shimada S, Morikawa M, et al.  Recurrent pregnancy loss (etiology of thrombophilia). Semin Thromb Hemost. 2001;27:121–129
  34. Carp HJA, Salomon O, Seidman D, Dardik R, Rosenberg N, Inbal A. Prevalence of genetic markers for thrombophilia in recurrent pregnancy loss. Hum Reprod [In press].
  35. Ogasawara MS, Aoki K, Katano K, Ozaki Y, Suzumori K. Factor XII but not protein C, protein S, antithrombin III, or factor XIII is a predictor of recurrent miscarriage. Fertil Steril. 2001;75:916–919
  36. Daya S, Gunby J. The effectiveness of allogeneic leucocyte immunization in unexplained primary recurrent spontaneous abortion. Am J Reprod Immunol. 1994;32:294–302
  37. Carp HJA, Toder V, Orgad S, Aviram A, Danieli M, Mashiach S, et al.  Karyotype of the abortus in recurrent miscarriage. Fertil Steril. 2001;5:678–682
  38. Ogasawara M, Aoki K, Okada S, Suzumori K. Embryonic karyotype of abortuses in relation to the number of previous miscarriages. Fertil Steril. 2000;73:300–304
  39. Stern JJ, Dorfman AD, Gutierrez-Najar MD. Frequency of abnormal karyotype among abortuses from women with and without a history of recurrent spontaneous abortion. Fertil Steril. 1996;65:250–253
  40. Wegmann TG. The cytokine basis for cross-talk between the maternal immune and reproductive systems. Curr Opin Immunol. 1990;2:765–769
  41. King A, Jokhi PP, Burrows TD, Gardner L, Sharkey AM, Loke YW. Functions of human decidual NK cells. Am J Reprod Immunol. 1996;35:258–260
  42. Yui J, Garcia-Lloret M, Wegmann TG, Guilbert LJ. Cytotoxicity of tumor necrosis factor-alpha and gamma-interferon against primary human placental trophoblast. Placenta. 1994;15:819–835
  43. Mirkes PE. Cellular responses to stress. In:  Kavlock RJ,  Daston GP editor. Drug toxicity in embryonic development. Vol. I:New York: Springer-Verlag; 1997;p. 245–276
  44. Gendron RL, Nestel FP, Lapp WS, Baines MG. Lipopolysaccharide-induced fetal resorption in mice is associated with the intrauterine production of tumor necrosis factor-alpha. J Reprod Fertil. 1990;90:395–402
  45. Matsuzaki N, Neki R, Sawai K, Shimoya K, Okada T, Sakata M. Soluble IL-6 receptor in the sera of pregnant women forms a complex with IL6 and augments human chorionic gonadotropin production by normal human trophoblast through binding to the IL-6 signal transducer. J Clin Endocrinol Metab. 1995;80:2912–2917
  46. Ten Cate H, Timmerman JJ, Levi M. The pathophysiology of disseminated intravascular coagulation. Thromb Haemost. 1999;82:713–717
  47. Rai R, Regan L. Thrombophilia and adverse pregnancy outcome. Semin Reprod Med. 2000;18:369–377
  48. Laude I, Rongieres-Bertrand C, Bayer-Neumann C, Wolf M, Mairovitz V, Hugel B, et al.  Circulating procoagulant microparticles in women with unexplained pregnancy loss (a new insight). Thromb Haemost. 2001;85:18–21

PII: S0015-0282(02)03152-7

Fertility and Sterility
Volume 78, Issue 1 , Pages 58-62 , July 2002

Article Tools